Chronic Lower Back Pain Market
Chronic Lower Back Pain Market - Global Industry Assessment & Forecast
#
Pages:
210
Base Year:
2023
Oct - 2024
Format:
Report Code:
VMR-2975
Segments Covered
By
Drug Class Non-steroidal Anti-Inflammatory Drugs, Antidepressants, Analgesic, Opioids, Others
-
By
Route of Administration Oral, Topical, Others
-
By
Distribution Channel Hospital Pharmacies, Retail & Online Pharmacies
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 2.5 Billion |
 Revenue 2032:
|
USD 5.52 Billion |
 Revenue CAGR
(2024 - 2032): |
9.2% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Chronic Lower Back Pain Market Segment Analysis
- Chronic Lower Back Pain Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- Chronic Lower Back Pain Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Oral
- Topical
- Others
- Chronic Lower Back Pain Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacies
- Retail & Online Pharmacies
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
-
North America Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
-
North America Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- U.S.
- U.S. Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- U.S. Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- U.S. Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- U.S. Chronic Lower Back Pain Market, by Drug Class
- Canada
- Canada Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- Canada Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- Canada Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- Canada Chronic Lower Back Pain Market, by Drug Class
-
Mexico
- Mexico Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- Mexico Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- Mexico Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- Mexico Chronic Lower Back Pain Market, by Drug Class
-
North America Chronic Lower Back Pain Market, by Drug Class
- Europe
-
Europe Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
-
Europe Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
-
Europe Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- U. K.
- U.K. Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- U.K. Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- U.K. Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- U.K. Chronic Lower Back Pain Market, by Drug Class
- France
- France Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- France Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- France Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- France Chronic Lower Back Pain Market, by Drug Class
-
Germany
- Germany Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- Germany Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- Germany Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- Germany Chronic Lower Back Pain Market, by Drug Class
-
Italy
- Italy Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- Italy Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- Italy Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- Italy Chronic Lower Back Pain Market, by Drug Class
-
Spain
- Spain Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- Spain Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- Spain Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- Spain Chronic Lower Back Pain Market, by Drug Class
-
Rest of Europe
- Rest of Europe Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- Rest of Europe Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- Rest of Europe Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- Rest of Europe Chronic Lower Back Pain Market, by Drug Class
-
Europe Chronic Lower Back Pain Market, by Drug Class
- Asia Pacific
-
Asia Pacific Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
-
Asia Pacific Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
-
Asia Pacific Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- China
- China Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- China Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- China Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- China Chronic Lower Back Pain Market, by Drug Class
- Japan
- Japan Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- Japan Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- Japan Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- Japan Chronic Lower Back Pain Market, by Drug Class
-
Germany
- Germany Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- Germany Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- Germany Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- Germany Chronic Lower Back Pain Market, by Drug Class
-
India
- India Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- India Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- India Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- India Chronic Lower Back Pain Market, by Drug Class
-
South Korea
- South Korea Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- South Korea Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- South Korea Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- South Korea Chronic Lower Back Pain Market, by Drug Class
-
South East Asia
- South East Asia Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- South East Asia Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- South East Asia Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- South East Asia Chronic Lower Back Pain Market, by Drug Class
-
Rest of Asia Pacific
- Rest of Asia Pacific Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- Rest of Asia Pacific Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- Rest of Asia Pacific Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- Rest of Asia Pacific Chronic Lower Back Pain Market, by Drug Class
-
Asia Pacific Chronic Lower Back Pain Market, by Drug Class
- Latin America
-
Latin America Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
-
Latin America Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
-
Latin America Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- Brazil
- Brazil Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- Brazil Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- Brazil Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- Brazil Chronic Lower Back Pain Market, by Drug Class
- Argentina
- Argentina Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- Argentina Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- Argentina Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- Argentina Chronic Lower Back Pain Market, by Drug Class
-
Rest of Latin America
- Rest of Latin America Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- Rest of Latin America Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- Rest of Latin America Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- Rest of Latin America Chronic Lower Back Pain Market, by Drug Class
-
Latin America Chronic Lower Back Pain Market, by Drug Class
- Middle East & Africa
-
Middle East & Africa Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
-
Middle East & Africa Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
-
Middle East & Africa Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- GCC Countries
- GCC Countries Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- GCC Countries Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- GCC Countries Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- GCC Countries Chronic Lower Back Pain Market, by Drug Class
- South Africa
- South Africa Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- South Africa Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- South Africa Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- South Africa Chronic Lower Back Pain Market, by Drug Class
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Chronic Lower Back Pain Market, by Drug Class
- Non-steroidal Anti-Inflammatory Drugs
- Antidepressants
- Analgesic
- Opioids
- Others
- Rest of Middle East & Africa Chronic Lower Back Pain Market, by Route of Administration
- Oral
- Topical
- Others
- Rest of Middle East & Africa Chronic Lower Back Pain Market, by Distribution Channel
- Hospital Pharmacies
- Retail & Online Pharmacies
- Rest of Middle East & Africa Chronic Lower Back Pain Market, by Drug Class
-
Middle East & Africa Chronic Lower Back Pain Market, by Drug Class
- North America
FAQ
Frequently Asked Question
What is the global demand for Chronic Lower Back Pain in terms of revenue?
-
The global Chronic Lower Back Pain valued at USD 2.5 Billion in 2023 and is expected to reach USD 5.52 Billion in 2032 growing at a CAGR of 9.2%.
Which are the prominent players in the market?
-
The prominent players in the market are Johnson & Johnson Private Limited, Medtronic, Endo Pharmaceuticals Inc., Sanofi, Merck & Co Inc., Koninklijke Philips N.V., Vertebral Technologies, Inc., Boston Scientific Corporation, Dr. Reddy’s Laboratories Ltd., Astellas Pharma Inc., SpineThera Inc., Pfizer Inc, Teva Pharmaceutical Industries Ltd..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 9.2% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Chronic Lower Back Pain include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Chronic Lower Back Pain in 2023.
